Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Open Access
- 29 June 2024
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 14 (13) , 1390
Abstract
Geriatric assessment management is a multidimensional tool used to evaluate prognosis for clinical outcomes and targets for interventions in older adults with cancer receiving chemotherapy. In this review, we evaluated the possible application of geriatric assessment management (GAM) in hematological malignancies. In older patients with Diffuse Large B Cell Lymphoma, GAM might be helpful in both predicting planned hospital admissions and improving quality of life. In chronic myeloid leukemia, the Charlson Comorbidity Index demonstrates how comorbidities could affect treatment compliance and overall outcomes. In multiple myeloma, the application of different scores such as the International Myeloma Working Group Frailty Index and the Revised Myeloma Comorbidity Index can identify frail patients who need suitable interventions in treatment plan (reducing drug dose or changing treatment). Therefore, including GAM in the management plan of older patients with hematological malignancies may direct and optimize cancer care.Keywords
This publication has 103 references indexed in Scilit:
- Effects of different modalities of transcranial magnetic stimulation on post-stroke cognitive impairment: a network meta-analysisNeurological Sciences, 2024
- Risk factors and the nomogram model for malnutrition in patients with nasopharyngeal carcinomaSupportive Care in Cancer, 2024
- Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B‐cell lymphomaCancer Medicine, 2023
- Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trialsAnnals of Hematology, 2023
- Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysisAnnals of Hematology, 2022
- Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With CancerJAMA Oncology, 2021
- Communication With Older Patients With Cancer Using Geriatric AssessmentJAMA Oncology, 2020
- A randomized phase II trial of geriatric assessment and management for older cancer patientsSupportive Care in Cancer, 2017
- Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysisJournal of Cancer Research and Clinical Oncology, 2017
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) scoreCancer, 2011